Global Sterility Testing Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
MarketResearch.Biz delivers in-depth insights on the sterility testing market in its upcoming report titled, “Global Sterility Testing Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global sterility testing market is estimated to be US$ XX million in 2017 end, and is expected to reach US$ XX million registering a healthy CAGR of XX%, in the next 10 years. Membrane filtration method continues to maintain its dominance in terms of preference and revenue contribution, as it can not only circumvent, but also overcome the activity of antibiotics for which there exist practically little inactivating agents. Also, kits and reagents are the most used products currently. Due to rising government support for pharmaceutical and biological manufacturing, it is expected to account for largest revenue share.
This upcoming report offers in-depth insights, revenue details, and other vital information regarding the global sterility testing market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report contains insightful and detailed information regarding the various key players operating in the global market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global sterility testing market report has been segmented on the basis of product, test, application, and region.
Sterility testing is a critical and vital sterilization test that must be performed by trained and qualified laboratory personnel, to assess whether a sterilized pharmaceutical product is free from contaminating microorganisms. Sterility testing is essential for detecting presence of viable forms of microorganisms in or on pharmacopoeal preparations. It is mandatory to perform such tests in a clean and aseptic area to avoid accidental contamination. Sterility testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize risk of product contamination.
Factors driving growth of the global sterility testing market include growth in pharmaceutical and biotechnology industries, rising R&D activities in life science research, and surge in launch of new drugs in markets globally. Increasing government support for pharmaceutical and biotechnology industries and rise in demand for sterilized products and their exclusivity in healthcare industry are accelerating market growth.
However, lengthy approval procedures, stringent regulatory policies, and high-degree of market consolidation are factors restraining market growth. High level of competition between key players in the market is projected to create challenges for new entrants operating in emerging markets.
The market in Asia Pacific is expected to witness rapid growth and contribute major revenue share to the global sterility testing market. Countries in Asia Pacific represent major revenue generation potential, owing to rising initiatives by governments and private organizations for sterility testing research, rising outsourcing in pharmaceutical sector to emerging economies such as India and China, and escalating outlay on research in life sciences. The market in North America is also expected to contribute significantly over the forecast period.
Global sterility testing market, by product
- Kits and Reagents
Global sterility testing market, by test
- Membrane Filtration
- Direct Inoculation
- Other Sterility Tests
Global sterility testing market, by application
- Pharmaceutical and Biological Manufacturing
- Medical Devices Manufacturing
- Others Applications
Global sterility testing market, by region
- North America
- Latin America
- Asia Pacific
- Rest of the World (RoW)
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Charles River Laboratories International, Inc.
- BioMérieux SA
- SGS S.A.
- Sartorius AG
- WuXi AppTec
- Thermo Fisher Scientific, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!